Evaluating Vandetanib in the Treatment of Medullary Thyroid Cancer: Patient-Reported Outcomes
Cancer Management and Research - New Zealand
doi 10.2147/cmar.s127848
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 1, 2019
Authors
Publisher
Informa UK Limited